Dow Jones Newswires: Impact Biomedical files for IPO

Impact Biomedical has filed for an initial public offering, according to a filing with the Securities and Exchange Commission.

Previous post : Ardelyx wins long battle for FDA approval of kidney-disease treatment 
Next post : Elon Musk’s X to start charging new, unverified users in test program in two countries